Mindsense: Biomarkers aren't boring
Diagnostics has not been a field of interest for venture capitalists - the margins have been too low. Mindsense Biosystems Ltd. believes it can do better.
"We know the diagnostics field is quite boring, business-wise, but it's boring for good reasons," said CEO Nir Nimrodi. "Much of the innovation is just improved automation or performance. But new biomarkers, such as PSA for prostate cancer, or